CM:TSX
Canadian Imperial Bank of Commerce
Data as of 2026-03-10 - not real-time
CA$132.90
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Canadian Imperial Bank of Commerce (CM) is trading at C$132.9, comfortably above its 50‑day SMA (C$130.3) but below the 20‑day SMA (C$135.0), indicating a short‑term pull‑back within a broader bullish trend. The stock enjoys a solid dividend yield of 3.16% with a modest payout ratio (≈41%), and recent news highlights its appeal as a dividend play. Valuation metrics are attractive – a trailing P/E of 14.1 versus the industry average of 17.4 and an upside potential of roughly 8% to the next resistance level (C$143.8). Operating margins are strong (44.7%) and revenue is growing at 16.7% YoY, though operating cash flow is negative, which warrants monitoring. Overall, the combination of undervalued pricing, steady dividend income, and supportive analyst sentiment (Buy) makes CM a compelling candidate for income‑focused investors, while the technical setup suggests cautious optimism for near‑term price appreciation.
Investors should weigh the modest volatility (≈23% 30‑day) and low beta (~0.42) against the bank’s strong fundamentals and dividend sustainability before positioning.
Investors should weigh the modest volatility (≈23% 30‑day) and low beta (~0.42) against the bank’s strong fundamentals and dividend sustainability before positioning.
Trading Recommendations
Short Term
< 1 yearhold
Conviction: 7/10
Key Factors
- Price near technical support at C$128.6
- Strong dividend yield supporting total return
- MACD bearish crossover suggesting limited upside in the next few weeks
Medium Term
1–3 yearsbuy
Conviction: 8/10
Key Factors
- Revenue growth of 16.7% and high operating margins
- Undervalued relative to peers (P/E 14.1 vs industry 17.4)
- Analyst consensus (Buy) and upside potential to C$143.8
Long Term
> 3 yearsbuy
Conviction: 9/10
Key Factors
- Sustainable dividend backed by strong capital and low payout ratio
- Stable Canadian banking environment with low beta
- Continued earnings expansion reflected in forward EPS and lower forward P/E
Key Metrics & Analysis
Financial Health
Revenue Growth16.70%
Profit Margin33.53%
P/E Ratio14.1
ROE14.75%
ROA0.85%
P/B Ratio1.9
Op. Cash FlowCA$-26968000512
Industry P/E17.4
Technical Analysis
TrendBullish
RSI47.7
SupportCA$128.59
ResistanceCA$143.80
MA 20CA$135.00
MA 50CA$130.33
MA 200CA$113.62
MACDBearish
VolumeIncreasing
Fear & Greed Index75.89
Valuation
Target PriceCA$143.97
Upside/Downside8.33%
GradeUndervalued
TypeBlend
Dividend Yield3.16%
Risk Assessment
Beta0.42
Volatility22.99%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
More Tickers
This analysis may contain inaccuracies. Not financial advice. Always do your own research before making any investment decisions.